Portfolio company
Spero
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops medicines for immune-mediated diseases and multi-drug resistant bacterial infections for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Paratek
This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.
Qpex Biopharma
This biopharmaceutical company develops novel anti-infective therapies for patients with drug-resistant bacterial infections in inpatient and outpatient settings.
SelectX Pharmaceuticals
This biopharmaceutical company develops small molecule antimicrobials and therapeutics for unmet medical needs using a genetic chemistry platform for patients with infectious diseases.
SANTERO
This company develops small molecule medicines targeting bacterial dormancy to treat patients with chronic, treatment-refractory respiratory, orthopaedic and wound-related infections.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Selecta Biosciences
This biopharmaceutical company develops nanoparticle immunomodulatory drugs to treat and prevent human diseases for patients with autoimmune disorders and rare genetic conditions.
C10 PHARMA
This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
